Pharmacokinetics and metabolism of the proton pump inhibitor pantoprazole in man

Drugs of Today

Volumn 35, Issue 10, 1999, Pages 765-772

  Radhofer Welte, S ^a  

^a NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; BENZIMIDAZOLE DERIVATIVE; CAFFEINE; CARBAMAZEPINE; DIAZEPAM; DICLOFENAC; DIGOXIN; GLIBENCLAMIDE; METOPROLOL; NIFEDIPINE; PANTOPRAZOLE; PHENAZONE; PHENPROCOUMON; PHENYTOIN; PROTON PUMP INHIBITOR; THEOPHYLLINE; WARFARIN;

AREA UNDER THE CURVE; DOSE TIME EFFECT RELATION; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; REVIEW; STOMACH ACID SECRETION; STOMACH ULCER;

EID: 0033392132     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.10.561695     Document Type: Review

References (33)

1. Fitton, A., Wiseman, L. Pantoprazole: A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996, 51: 460-82.
2. +-ATPase inhibitor (BY1023/ SK&F96022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up. J Chromatogr 1990, 529: 389-401.
3. +-ATPase inhibitor pantoprazole after single intravenous administration. Int J Clin Pharmacol Ther 1994, 32: 44-50.
4. Pue, M.A., Laroche, J., Meineke, I., De Mey, C. Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Eur J Clin Pharmacol 1993, 44: 575-8.
5. Huber, R., Hartmann, M., Bliesath, H., Lühmann, R., Steinijans, V.W., Zech, K. Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther 1996, 34: 185-94.
6. 14C-labelled pantoprazole to young healthy male volunteers. Pharm World Sci 1993, 15: L7.
7. Meyer, U.A. Interaction of proton pump inhibitors with cytochromes P450: Consequences for drug interactions. Yale J Biol Med 1996, 69: 203-9.
8. De Mey, C., Meineke, I., Steinijans, V.W. et al. Pantoprazole lacks interaction with antipyrine, either by inhibition or induction. Int J Clin Pharmacol Ther 1994, 32: 98-106.
9. Steinijans, V.W., Huber, R., Hartmann, M. et al. Lack of pantoprazole interactions in man: An updated review. Int J Clin Pharmacol Ther 1996, 34: 243-62.
10. Schulz, H.-U., Hartmann, M., Steinijans, V.W. et al. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. Int J Clin Pharmacol Ther Toxicol 1991, 29: 369-75.
11. Tanaka, M., Yamazaki, H., Hakasui, H., Nakamichi, N., Sekino, H. Differential stereo-selective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole - A preliminary study. Chirality 1997, 9: 17-21.
12. Simon, B., Müller, P., Marinis, E. et al. Effect of repeated oral administration of BY1023/ SK&F96022, a new substituted benzimidazole derivative, on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990, 4: 373-9.
13. +-ATPase inhibitor (BY1023/ SK&F96022) in healthy volunteers. Z Gastroenterol 1990, 28: 443-7.
14. Andersson, T. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 1996, 31: 9-28.
15. Steinijans, V.W., Huber, R., Hartmann, M. et al. Lack of pantoprazole drug interactions in man. Int J Clin Pharmacol Ther 1994, 32: 385-99.
16. Hartmann, M., Huber, R., Bliesath, H. et al. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. Int J Clin Pharmacol Ther 1995, 33: 481-5.
17. Bliesath, H., Huber, R., Steinijans, V.W., Koch, H.J., Kunz, K., Wurst, W. Pantoprazole does not interact with nifedipine in man under steady-state conditions. Int J Clin Pharmacol Ther 1996, 34: 51-5.
18. Duursema, L., Müller, F.O., Schall, R. et al. Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br J Clin Pharmacol 1995, 39: 700-3.
19. Bliesath, H., Huber, R., Steinijans, V.W., Koch, H.J. Wurst, W., Mascher, H. Lack of pharmacokinetic interaction between pantoprazole and diclofenac. Int J Clin Pharmacol Ther 1996, 34: 152-6.
20. Middle, M.V., Müller, F.O., Schall, R. et al. No influence of pantoprazole on the pharmacoki-netics of phenytoin. Int J Clin Pharmacol Ther 1995, 33: 304-7.
21. Huber, R., Bliesath, H., Hartmann, M. et al. Pantoprazole does not interact with the pharmacokinetics of carbamazepine. Int J Clin Pharmacol Ther 1998, 36: 521-4.
22. Middle, M.V., Müller, F.O., Schall, R., Hundt, H.K.L., Mogilnicka, E.M., Beneke, P.C. Effect of pantoprazole on ovulation suppression by a low-dose hormonal contraceptive. Clin Drug Invest 1995, 9: 54-6.
23. +-ATPase inhibitor pantoprazole. Gastroenterology 1994, 106 (Suppl.): A91.
24. Breuel, H.P., Hartmann, M., Bondy, S. et al. Pantoprazole in the elderly: No dose-adjustment. Gut 1994, 35 (Suppl. 4): A77.
25. Brunner, G., Chang, J., Hartmann, M. et al. Pharmacokinetics of pantoprazole in patients with liver cirrhosis. Med Klinik 1994, 89 (Suppl. 1): 189.
26. Lins, R.L., De Clerq, I., Hartmann, M., Bliesath, H., Lühmann, R., Wurst, W. Pharmacokinetics of the proton pump inhibitor pantoprazole in patients with severe renal impairment. Gastroenterology 1994, 106 (Suppl.): A126.
27. Ehrlich, A., Fuder, H., Hartmann, M. et al. Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. Eur J Clin Pharmacol 1996, 51: 277-81.
28. Koch, H.J., Hartmann, M., Bliesath, H. et al. Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers. Int J Clin Pharmacol Ther 1996, 34: 420-3.
29. Walter-Sack, I.E., Bliesath, H., Stoetzer, F. et al. Lack of pharmacokinetic and pharmacodynamic interaction between pantoprazole and glibenclamide in humans. Clin Drug Invest 1988, 15: 253-60.
30. Kliem, V., Bahlmann, J., Hartmann, M., Huber, R., Luehmann, R., Wurst, W. Pharmacokinetics of pantoprazole in patients with end-stage renal failure. Nephrol Dial Transplant 1998, 13: 1189-93.
31. Hartmann, M., Zech, K., Bliesath, H. et al. Pantoprazole lacks induction of CYP1A2 activity in man. Int J Clin Pharmacol Ther 1999, 37: 159-64.
32. Gugler, R., Hartmann, M., Rudi, J. et al. Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. Br J Clin Pharmacol 1996, 42: 249-52.
33. Teyssen, S., Singer, M.V., Heinze, H. et al. Pantoprazole does not influence the pharmacokinetics of ethanol in healthy volunteers. Gastroenterology 1996, 110: A277.